LISA REITER: Open Payments
NPI 1669727749 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 10 payments from 5 companies in 2025. Trend: 2023 $726 · 2024 $627 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $140 |
| Regeneron Healthcare Solutions, Inc. | 5 | $127 |
| Actelion Pharmaceuticals US, Inc. | 2 | $125 |
| Verona Pharma, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: DUPIXENT, UPTRAVI, Ohtuvayre, JASCAYD.
Industry payments across NV — which companies pay providers there.
